AlphaCentric Advisors »

Trevi Therapeutics shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $284k 23k 12.52

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Vanguard Group
Vivo Capital
Marshall Wace
Alliancebernstein
Rubric Capital Management
OrbiMed Advisors
FMR
MPM Oncology Impact Management
Wellington Management Company
Viking Global Investors
Octagon Capital Advisors
Eventide Asset Management

View all funds holding Trevi Therapeutics